DIMAPUR, JANUARY 23: After a week that witnessed an open display of reservation by some frontline workers in the State against the Covid-19 vaccine even as 4480 healthcare workers were reported to have received the vaccine shots, Health authorities in Nagaland have underscored the importance of vaccines as the safest means to curb the pandemic.
In its weekly COVID bulletin, the Integrated Disease Surveillance Programme of the Department of Health and Family Welfare informed that more than 60 million doses have been administered across the globe, in 55 countries including India.
“Vaccination offers the safest way to cut short the pandemic and reduce mortality. The need for vaccination is more urgently felt in the threat of emergence of many SARS COV 2 variants as more transmission will lead to emergence of more variants which are poorly understood. The goal is to achieve maximum immunity of the population through vaccines and maintenance of COVID-19 appropriate behaviours at the same time,” it stated.
In the first week of COVID-19 vaccination, Nagaland inoculated 4480 healthcare workers (doctors, nurses and support staff) across 11 districts by the Covishield vaccine, led by Principal Director of HFW and Mission Director of NHM, the department informed.
No adverse events which needed medical management were reported, it added.
During the same period, India vaccinated more than 10 lakh healthcare workers by two vaccines, Covishield and Covaxin, it informed.
According to the department, the Covishield vaccine, which Nagaland had received for the first phase, has undergone all pre-clinical and clinical phases and is already use in 5 other countries.
It informed that Covishield has more than 70% efficacy, and the World Health Organization has maintained that a vaccine with 50 % efficacy is acceptable in a pandemic as such.
As for the other vaccine approved for use in India, Covaxin, it informed that initial clinical trials has proven to be very safe and is already in use among healthcare workers in other states of the country. “Dr VK Paul, Chairman of National Expert Group on COVID-19 vaccination, was vaccinated by Covaxin,” it added.
As with all other vaccines and injectables, a small fraction of the beneficiaries will experience mild fever, pain at injection site, body ache, lethargy, headache etc which will subside in a day or two or with medicines like paracetamol, the department stated.
“These symptoms are just the body reacting to the vaccine, and is normal. The same is observed even in routine immunization of children. No long-term side effects are expected as these vaccines are proven established technologies. Both vaccines do not have the live virus and will not cause infection too,” it added.
Who should not receive the vaccine
a. Anyone with history of anaphylactic or allergic reaction to previous dose of COVID-19 vaccine.
b. History of immediate or delayed onset allergic reaction / anaphylaxis to vaccines or other injectable therapies, pharmaceutical products, food items etc.
c. Pregnant and lactating women
d. Below 18 years of age
e. Those having active COVID-19 infection
f. COVID-19 patients who have received immunotherapy
g. Those who are acutely unwell and hospitalized for any medical condition.
*Pregnant mothers, lactating mothers and those below 18 years of age are not recommended for the COVID-19 vaccine since no clinical trials have been done for the mentioned categories and age groups. It is out of abundant precaution.
Meanwhile, in the past week, Nagaland recorded 33 fresh cases, out of which 17 were traced contacts. There were no COVID fatalities. (Page News Service)